{
  "basic_data": [
    {
      "cell_line_alt_name": "AIBNi007-A; GENIE 11",
      "cell_type": "iPSC",
      "frozen": "False",
      "hpscreg_name": "AIBNi007-A"
    }
  ],
  "generator": [
    {
      "group": "Australian Institute for Bioengineering and Nanotechnology"
    }
  ],
  "contact": [
    {
      "first_name": "Ernst",
      "name_initials": "J",
      "e_mail": "e.wolvetang@uq.edu.au",
      "last_name": "Wolvetang",
      "group": "Wolvetang-AIBN"
    }
  ],
  "publications": [
    {
      "last_author": "Lata Vadlamudi",
      "year": "2022.0",
      "first_author": "Zoe L. Hunter",
      "doi": "10.1016/j.scr.2022.102673",
      "journal": "Stem Cell Research",
      "title": "Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening"
    }
  ],
  "donor": [
    {
      "disease_name": "Epilepsy"
    }
  ],
  "induced_derivation": [
    {
      "i_source_cell_origin_term": "blood",
      "non_int_vector_name": "CytoTune 2.0 Sendai Virus Kit (ThermoFisher Scientific)",
      "i_source_cell_type_term": "Peripheral Blood Mononuclear Cells (PBMCs)",
      "non_int_vector": "Sendai virus"
    }
  ],
  "ethics": [
    {
      "institutional_HREC": "University of Queensland Ethics Committee"
    }
  ],
  "culture_medium": [
    {
      "co2_concentration": "0.05",
      "passage_method": "EF"
    }
  ]
}